Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
151-165 of 2208 results
Shire and Baxalta agree on $32bn merger
By PBR Staff Writer
Irish drugmaker Shire has agreed to merge with American biopharmaceutical firm Baxalta under a transaction worth about $32bn.
Production & Manufacturing > Manufacturing > News
Agenus acquires PhosImmune with novel class of cancer neoantigens
Agenus has acquired PhosImmune, a company that has discovered an entirely new portfolio of cancer neoantigens.
Production & Manufacturing > Manufacturing > News
Seattle Genetics and Bristol-Myers Squibb start new trial assessing combination of Adcetris and Opdivo
By PBR Staff Writer
US-based Seattle Genetics and Bristol-Myers Squibb have initiated a new trial assessing Adcetris (brentuximab vedotin) in combination with Opdivo (nivolumab).
Production & Manufacturing > Manufacturing > News
Samsung breaks ground on third biopharmaceutical manufacturing plant in South Korea
By PBR Staff Writer
Samsung BioLogics has broken ground on its third biopharmaceutical manufacturing plant in Incheon Free Economic Zone, Songdo, South Korea.
Production & Manufacturing > Manufacturing > News
AAIPharma Services/Cambridge Major Laboratories upgrade small molecule manufacturing capabilities at Weert site
AAIPharma Services Corp. / Cambridge Major Laboratories has upgraded its small molecule manufacturing capabilities at its site in Weert, Netherlands with the installation of a DE Dietrich Agitated Filter Dryer for controlled isolation of Intermediates and Active Pharmaceutical Ingredients (APIs).
Production & Manufacturing > Manufacturing > News
AstraZeneca to buy 55% stake in Acerta Pharma for $4bn
By PBR Staff Writer
AstraZeneca has agreed to acquire a 55% stake in privately-owned biotech firm Acerta Pharma for $4bn.
Production & Manufacturing > Manufacturing > News
AstraZeneca strengthens Chinese operations and respiratory business with new deals
By PBR Staff Writer
AstraZeneca has announced two new agreements, one to develop next-generation biologics in China, and the other to expand its respiratory franchise.
Production & Manufacturing > Manufacturing > News
Sanofi, Boehringer Ingelheim in negotiations for asset swap
By PBR Staff Writer
Sanofi and Boehringer Ingelheim are in exclusive talks on a potential asset swap that would see the French pharmaceutical firm swap its animal health unit (Merial) with the German company's consumer healthcare (CHC) business.
Production & Manufacturing > Manufacturing > News
AstraZeneca considering Acerta Pharma bid to acquire blood cancer drug
By PBR Staff Writer
AstraZeneca is in negotiations with cancer drug maker Acerta Pharma on a potential deal to strengthen its cancer drug portfolio.
Production & Manufacturing > Manufacturing > News
Lannett acquires Kremers Urban Pharmaceuticals for $1.23bn
By PBR Staff Writer
Drug maker Lannett has acquired Kremers Urban Pharmaceuticals (KU) for about $1.23bn.
Production & Manufacturing > Manufacturing > News
Samsung Biologics to invest $736m to build new drug manufacturing plant in South Korea
By PBR Staff Writer
Samsung Biologics is planning to invest KRW850bn ($736m) to construct a new drug manufacturing plant in Songdo, South Korea.
Production & Manufacturing > Manufacturing > News
AAIPharma/Cambridge Major Laboratories to invest $15m for laboratories expansion
AAIPharma Services Corp./Cambridge Major Laboratories announced the planned investment of at least $15.8m to expand its laboratories and global headquarters in Wilmington, NC.
Production & Manufacturing > Manufacturing > News
Xellia Pharmaceuticals acquires Hikma's Ohio manufacturing plants
By PBR Staff Writer
Xellia Pharmaceuticals has acquired manufacturing facilities in Bedford, Ohio, US from a subsidiary of Hikma Pharmaceuticals.
Production & Manufacturing > Manufacturing > News
Pershing Square increases stake in Valeant Pharmaceuticals
By PBR Staff Writer
Pershing Square Capital Management has increased its interest in Valeant Pharmaceuticals International to 9.9%, making it the second largest shareholder in the company.
Production & Manufacturing > Manufacturing > News
Pfizer acquires Allergan in $160bn deal
By PBR Staff Writer
Allergan has agreed to merge with Pfizer in a $160bn deal that will create the world's largest pharmaceutical company.
Production & Manufacturing > Manufacturing > News
151-165 of 2208 results